Professor Ildiko Lingvay, MD, MPH, MSCS
University of Texas (UT) Southwestern Medical Center, Dallas, TX, USA

Dr. Ildiko Lingvay is Professor of Medicine in the Division of Endocrinology as well as the Department of Population and Data Sciences at UT Southwestern Medical Center. Dr. Lingvay is the Medical Director of the Office of Clinical Trials Management, overseeing all clinical trials at UT Southwestern.

Dr Lingvay leads a research program that focuses on clinical research in the field of obesity and Type 2 diabetes, with the ultimate goal to improve the lives of all patients who suffer so many health consequences as a result of their medical problems. Her research interests span the spectrum from pathophysiology of the disease to treatment algorithms and comparative effectiveness of various therapeutic approaches. Dr Lingvay sees patients at the UT clinics and hospitals as well as the Parkland Health & Hospital System.

Dr Lingvay is an active member of the American Diabetes Association, where she has served on several committees, including the Organizing Committee for the 2017-2019 Annual Scientific Sessions, Focus on Fellows Advisory Board, and most recently the WIN-ADA Advisory Board. She has participated in many clinical trials and has a special interest in cardiovascular trials in diabetes. She authored over 80 publications in major medical journals and authored chapters in several diabetes textbooks.